Kunal Jain, MD
Otolaryngology · Houston, TXNPI 1033344387
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,725 of the $11,364 with a category attached, or 85.6%. Johnson & Johnson accounts for 88.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $10,911 and has fallen 98.2% since, to $202 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $541.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$10K
- Medical Device Business Services, Inc.$823
- Intersect ENT, Inc.$145
- Ipsen Biopharmaceuticals, Inc$140
- Axogen$67
- Intuitive Surgical$40
- plus $90 from 4 others
What the payments were for
- Consulting fees$9,72586%
- Travel & lodging$8167%
- Food & beverage$8227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 6 | $10,059 |
| Medical Device Business Services, Inc. | 6 | $823 |
| Intersect ENT, Inc. | 1 | $145 |
| Ipsen Biopharmaceuticals, Inc | 1 | $140 |
| Axogen | 2 | $67 |
| Intuitive Surgical | 1 | $40 |
| Biotissue Holdings Inc. | 1 | $32 |
| Tactile Systems Technology Inc | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Optinose US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,364 in reported general payments places this provider in the 90th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $191 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Houston
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ron KarniHouston$317K
- Martin CitardiHouston$245K
- Michael KaplanHouston$202K
- Masayoshi TakashimaHouston$167K
- William YaoHouston$154K
- Andrew HuangHouston$137K
- Manish WaniHouston$100K
- Shane PahlavanHouston$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.